Intended for healthcare professionals

Papers

PapersNicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow upCommentary: Progress on nicotine replacement therapy for smokers

BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7179.285 (Published 30 January 1999) Cite this as: BMJ 1999;318:285

Nicotine nasal spray

EDITOR - Blondal et al (1) make a valuable contribution to the
literature. However commercial snuff is a cheap and effective way of
providing intranasal nicotine to reduce craving for smoked tobacco. There
is no evidence that snuff will be hazardous over the seven month period
recommended. The financial cost of snuff to the individual and to society
is minimal by comparison.

Alasdair J Macdonald,
Consultant psychiatrist and former smoker,
Garlands Hospital,
Carlisle CA13SX

1 Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A.
Nicotine nasal spray with nicotine patch for smoking cessation: randomised
trial with six year follow up. BMJ 1999:318:285-9. (30 Jan)

Competing interests: No competing interests

04 February 1999
Alasdair J Macdonald